SCHEMBL2302907

SCHEMBL2302907

CCN(CC)c1ccc(/N=N/c2ccc3c(c2)OCCO3)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 8/20 0.49
MEN1 O00255 6/20 0.49
MAPT P10636 11/20 0.47
RAB9A P51151 8/20 0.47
NPC1 O15118 7/20 0.47
MAPK1 P28482 6/20 0.47
SMN1; SMN2 Q16637 6/20 0.45
ALDH1A1 P00352 4/20 0.45
NCOA3 Q9Y6Q9 1/20 0.45
TDP1 Q9NUW8 5/20 0.44
KDM4E B2RXH2 3/20 0.44
LMNA P02545 2/20 0.44
ADRA2A P08913 2/20 0.44
ADRA2B P18089 2/20 0.44
ADRA2C P18825 2/20 0.44
GAA P10253 2/20 0.43
NR2F2 P24468 1/20 0.42
HSP90AA1 P07900 1/20 0.40
L3MBTL1 Q9Y468 4/20 0.40
POLB P06746 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2302912 1.00 KMT2A (0.49) KMT2AMEN1MAPTRAB9ANPC1
SCHEMBL15981870 0.78 MAPT (0.49) KMT2AMEN1MAPTRAB9ANPC1
SCHEMBL15981865 0.78 MAPT (0.49) KMT2AMEN1MAPTRAB9ANPC1
SCHEMBL13840331 0.75 MAPT (0.58) KMT2AMEN1MAPTRAB9ANPC1
SCHEMBL17279056 0.73 MAPT (0.57) KMT2AMEN1MAPTRAB9ANPC1
SCHEMBL21242233 0.73 MAPT (0.57) KMT2AMEN1MAPTRAB9ANPC1
SCHEMBL11324692 0.73 MAPT (0.57) KMT2AMEN1MAPTRAB9ANPC1
SCHEMBL11324690 0.73 MAPT (0.57) KMT2AMEN1MAPTRAB9ANPC1
SCHEMBL13181170 0.72 KMT2A (0.58) KMT2AMEN1MAPTRAB9ANPC1
SCHEMBL10000390 0.71 KMT2A (0.49) KMT2AMEN1MAPTRAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2908843-B1 TREATING CANCER AGENCY SCIENCE TECH & RES (SG) 2019-09-04 EP claimed
US-9889180-B2 Method of treating cancer AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2018-02-13 US claimed
US-20150258175-A1 METHOD OF TREATING CANCER AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2015-09-17 US claimed
EP-2908843-A1 METHOD OF TREATING CANCER Agency For Science, Technology And Research (SG) 2015-08-26 EP claimed
WO-2014077784-A1 METHOD OF TREATING CANCER AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2014-05-22 WO claimed
EP-2908843-B1 TREATING CANCER AGENCY SCIENCE TECH & RES (SG) 2019-09-04 EP disclosed
WO-2014077784-A1 METHOD OF TREATING CANCER AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2014-05-22 WO disclosed
WO-2011103016-A2 COMPOSITIONS AND METHODS FOR INHIBITING EZH2 THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2011-08-25 WO disclosed
WO-2009006577-A2 COMPOSITIONS AND METHODS FOR INHIBITING EZH2 THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2009-01-08 WO disclosed